What does this research mean for the field?

Long-term bulevirtide monotherapy is a safe and effective treatment for chronic hepatitis D that requires comprehensive patient management strategies, including universal screening and ongoing support. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The review aims to summarize the practical experiences and learnings derived from using bulevirtide for chronic hepatitis D management in Europe.

June 28, 2026Liver InternationalOpen Access

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

View Full Paper

Ask AI

Bookmark

Authors

MRMonica RaduLower Saxony State Museum ΜPΜargarita PapatheodoridiNational and Kapodistrian University of Athens HKHabiba KamalKarolinska University Hospital

Discussion

Member takes

Implication

Review highlights practical learnings and strategies for managing chronic hepatitis D with bulevirtide in Europe, indicating improved patient care.

Key Points

The review aims to summarize the practical experiences and learnings derived from using bulevirtide for chronic hepatitis D management in Europe.
Descriptive review of clinical practices and experiences with bulevirtide since its approval.
Assessment of patient care strategies and treatment adherence based on real-world evidence.
Discussion of changes in patient-doctor conversations regarding treatment expectations and disease management.
Bulevirtide treatment shows high adherence rates and persistence among patients.
Long-term bulevirtide monotherapy is found to be safe and effective, even for patients with compensated cirrhosis.
Improvements in liver fibrosis measurements and potential reduction in liver-related events are noted.

Cite This Study

Radu et al. (2026) studied this question.

synapsesocial.com/papers/6a40b96161bb0a67205c5b25 https://doi.org/10.1111/liv.70757

View Full Paper

Ask AI

Bookmark

Implication

Review highlights practical learnings and strategies for managing chronic hepatitis D with bulevirtide in Europe, indicating improved patient care.

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

Discussion

Member takes

Implication

Key Points

Cite This Study

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider